Knopp Gives Back

Biogen Idec deal in ALS allows Knopp Neurosciences to issue dividend to investors

Knopp gives back

After licensing its only clinical candidate to Biogen Idec Inc. (NASDAQ:BIIB), Knopp Neurosciences Inc. decided it could afford to give a dividend to investors.

Knopp granted Biogen Idec an exclusive, worldwide license to develop and commercialize dexpramipexole (KNS-760704).The small

Read the full 409 word article

How to gain access

Continue reading with a
two-week free trial.